Formulation And Evaluation Topical Cream By Extraction Of Sphagneticola Trilobata
Main Article Content
Abstract
Studying traditional medicine is a helpful way to discover potential new drugs. Sphagneticola is a large group of plants in the Asteraceae family, with around 60 different species. One of these, Sphagneticola trilobata (Linn.), has been used for a long time as a traditional herbal remedy in South America, China, Japan, and India to treat various health problems. Sphagneticola trilobata (L.) Pruski, known commonly as creeping oxeye, is a fastgrowing herb of the Asteraceae family with a impact of ethnomedicinal use across tropical regions. Traditionally employed in managing bleeding disorders, treating microbial infections, and supporting skin regeneration, the plant is now receiving greater scientific attention. This compiles and organizes botanical characteristics, phytochemical profiles, and pharmacological activity, emphasizing its hemostatic and dermatological regenerative properties. Data from in vitro and in vivo models reveal antioxidant, antimicrobial, antiinflammatory, cytotoxic, hepatoprotective, and antidiabetic effects. The paper also discusses extraction methods, merits and applications.
References
1) Ali MT, Al-Mahdy DA, El Fishawy AM, Otify AM. Sphagneticola trilobata (L.) Pruski: An updated exploration of its traditional applications, taxonomy, phytochemical profile and pharmacological properties. South African Journal of Botany. 2024 Nov 1;174:183-207.
2) Fucina G, Rocha LW, da Silva GF, Hoepers SM, Ferreira FP, Guaratini T, Cechinel Filho V, Lucinda-Silva RM, Quintão NL, Bresolin TM. Topical anti-inflammatory phytomedicine based on Sphagneticola trilobata dried extracts. Pharmaceutical biology. 2016 Nov 1;54(11):2465-74.
3) Balekar N, Katkam NG, Nakpheng T, Jehtae K, Srichana T. Evaluation of the wound healing potential of Wedelia trilobata (L.) leaves. Journal of Ethnopharmacology. 2012 Jun 14;141(3):817-24.
4) Balekar N, Nakpheng T, Srichana T. Wound-healing potential of grandiflorenic acid isolated from
Wedelia trilobata (L.) leaves. Songklanakarin Journal of Science &Technology. 2013 Sep 1;35(5).
5) Mardina V, Ilyas S, Halimatussakdiah H, Harmawan T, Tanjung M, Yusof F. Anticancer, antioxidant, and antibacterial activities of the methanolic extract from Sphagneticola trilobata (L.) J. F Pruski leaves. Journal of advanced pharmaceutical technology & research. 2021 Jul 1;12(3):222-6.
6) Remya GN, Sindu N. Comparative Evaluation of Phytochemical and Antibacterial Activity of Different Parts of Sphagneticola trilobata (L.) Pruski. Swapna, TS, Beevy, SS, Radhamany PM, Plant Genetic Resource Utilization Department of Botany University of Kerala India. 2021:143-8.
7) Balekar N, Nakpheng T, Srichana T. Wedelia trilobata L.: A phytochemical and pharmacological review. Chiang Mai Journal of Science. 2014 Jul 1;41(3):590-605.
8) Adetutu A, Morgan WA, Corcoran O. Ethnopharmacological survey and in vitro evaluation of wound-healing plants used in South-western Nigeria. Journal of ethnopharmacology. 2011 Sep 1;137(1):50-6.
9) Bohlmann F, Ziesche J, King RM, Robinson H. Eudesmanolides and diterpenes from Wedelia trilobata and an ent-kaurenic acid derivative from Aspilia parvifolia. Phytochemistry. 1981 Jan 1;20(4):751-6.
10) Pham DT, Huynh QC, Lieu R, Nguyen VB, Tran VD, Thuy BT. Controlled-release Wedelia trilobata L. flower extract loaded fibroin microparticles as potential anti-aging preparations for cosmetic trade commercialization. Clinical, Cosmetic and Investigational Dermatology. 2023 Dec 31:1109-21.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.